• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同步根治性切除可能改善结直肠癌肝转移患者的长期生存:一项倾向评分匹配研究。

Simultaneous curative resection may improve the long-term survival of patients diagnosed with colorectal liver metastases: A propensity score-matching study.

作者信息

Shi Xianmao, Huang Chunliu, Lu Shaolong, Luo Tao, Qin Zhengjun, Zhu Peng, Zhang Qingyuan, Wu Hualin, Wang Xiaobo, Chen Jie, Tang Weizhong

机构信息

Division of Colorectal and Anal Surgery, Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital, Nanning, China; Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Guangxi Medical University Cancer Hospital, Nanning, China.

Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China.

出版信息

Surgery. 2025 May;181:109144. doi: 10.1016/j.surg.2024.109144. Epub 2025 Jan 31.

DOI:10.1016/j.surg.2024.109144
PMID:39891967
Abstract

BACKGROUND

The benefit of simultaneous curative resection in patients with colorectal liver metastases has been unclear. Adjuvant chemotherapy is still considered an effective and priority treatment for advanced-stage colorectal patients.

METHODS

We retrospectively collected patients with colorectal liver metastases from January 2012 to October 2023 at the Guangxi Medical University Cancer Hospital. The baseline information was compared between a simultaneous curative resection group and a palliative treatment group. Propensity score matching with a 1:1 ratio was applied to develop comparable cohorts of curative resection and palliative treatment resection. Kaplan-Meier survival and Cox regression analyses were performed to determine the impact of curative resection on survival of colorectal liver metastasis patients. Prognostic nomogram and a web-version calculator were developed based on the multivariate Cox regression method. Then, the concordance index (C-index), receiver operating characteristic, calibration plots, and decision curves analysis were applied to evaluate the prognostic performance of the nomogram.

RESULTS

A total of 716 patients with colorectal liver metastases were enrolled in the study, of whom 131 patients received curative resection. There was no significant difference in terms of baseline information between the curative resection group and the palliative treatment group after propensity score matching. Multivariable Cox regression analysis showed that curative resection was an independent prognostic factor affecting overall survival (P = .001, hazard ratio = 1.95, 95% confidence interval 1.30-2.91). Compared with patients who did not receive curative resection, patients who received simultaneous curative resection had a significant improvement in overall survival before and after propensity score matching (P < .0001 and P = .0047, respectively). Overall survival nomogram showed excellent predictive performance with the C-indexes of 0.686 (95% confidence interval 0.556-0.792). The areas under the receiver operating characteristic curves were 0.75 (95% confidence interval 64.43-96.05), 0.75 (67.22-82.58), and 0.76 (66.10-85.98) for predicting 1-, 3-, and 5-year survival, respectively. The calibration plots and decision curves analysis also indicated the good predictability of the predictive nomogram. Finally, subgroup analysis further demonstrated a favorable impact of curative resection on overall survival in colorectal liver metastasis patients after propensity score matching.

CONCLUSIONS

Simultaneous curative resection may improve the overall survival of patients with colorectal liver metastases and is an independent and effective indicator for predicting overall survival. The nomogram may provide a personalized treatment strategy.

摘要

背景

结直肠癌肝转移患者同期根治性切除的获益尚不清楚。辅助化疗仍被认为是晚期结直肠癌患者的有效且优先的治疗方法。

方法

我们回顾性收集了2012年1月至2023年10月在广西医科大学附属肿瘤医院就诊的结直肠癌肝转移患者。比较同期根治性切除组和姑息治疗组的基线信息。采用1:1倾向评分匹配法构建根治性切除和姑息性切除的可比队列。进行Kaplan-Meier生存分析和Cox回归分析,以确定根治性切除对结直肠癌肝转移患者生存的影响。基于多变量Cox回归方法绘制预后列线图和网络版计算器。然后,应用一致性指数(C指数)、受试者工作特征曲线、校准图和决策曲线分析来评估列线图的预后性能。

结果

本研究共纳入716例结直肠癌肝转移患者,其中131例接受了根治性切除。倾向评分匹配后,根治性切除组和姑息治疗组的基线信息无显著差异。多变量Cox回归分析显示,根治性切除是影响总生存的独立预后因素(P = 0.001,风险比 = 1.95,95%置信区间1.30 - 2.91)。与未接受根治性切除的患者相比,接受同期根治性切除的患者在倾向评分匹配前后的总生存均有显著改善(分别为P < 0.0001和P = 0.0047)。总生存列线图显示出良好的预测性能,C指数为0.686(95%置信区间0.556 - 0.792)。预测1年、3年和5年生存的受试者工作特征曲线下面积分别为0.75(95%置信区间64.43 - 96.05)、0.75(67.22 - 82.58)和0.76(66.10 - 85.98)。校准图和决策曲线分析也表明预测列线图具有良好的可预测性。最后,亚组分析进一步证明了倾向评分匹配后根治性切除对结直肠癌肝转移患者总生存的有利影响。

结论

同期根治性切除可能改善结直肠癌肝转移患者的总生存,是预测总生存的独立有效指标。列线图可为个性化治疗策略提供依据。

相似文献

1
Simultaneous curative resection may improve the long-term survival of patients diagnosed with colorectal liver metastases: A propensity score-matching study.同步根治性切除可能改善结直肠癌肝转移患者的长期生存:一项倾向评分匹配研究。
Surgery. 2025 May;181:109144. doi: 10.1016/j.surg.2024.109144. Epub 2025 Jan 31.
2
Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.术后辅助化疗对于改善同时性切除的结直肠癌肝转移患者的长期生存率至关重要。
J Gastroenterol Hepatol. 2024 May;39(5):908-919. doi: 10.1111/jgh.16504. Epub 2024 Feb 7.
3
Lymphovascular invasion affects prognosis of colorectal cancer liver metastasis underwent primary resection: a propensity score matching analysis.淋巴管浸润影响接受原发灶切除的结直肠癌肝转移患者的预后:一项倾向评分匹配分析。
BMC Cancer. 2025 Apr 28;25(1):793. doi: 10.1186/s12885-025-14083-2.
4
Survival Benefits of Postoperative Chemotherapy in Patients With Colorectal Mucinous Adenocarcinoma: An Analysis Utilizing Propensity Score Matching From the Surveillance, Epidemiology, and End Results Database.术后化疗对结直肠黏液腺癌患者生存获益的影响:基于监测、流行病学和最终结果数据库的倾向评分匹配分析。
Am Surg. 2024 Nov;90(11):2969-2984. doi: 10.1177/00031348241257469. Epub 2024 Jun 7.
5
Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis.不可切除结直肠肝转移患者的姑息性手术:倾向评分匹配分析。
J Surg Oncol. 2014 Mar;109(3):239-44. doi: 10.1002/jso.23480. Epub 2013 Oct 25.
6
[Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].[双侧多发性结直肠癌肝转移患者肝切除术后的长期结局——倾向评分匹配分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Oct 25;23(10):976-983. doi: 10.3760/cma.j.cn.441530-20200414-00204.
7
A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy.一种新型的结直肠癌肝转移患者肝切除术后复发的预后列线图。
Cancer Med. 2021 Mar;10(5):1535-1544. doi: 10.1002/cam4.3697. Epub 2021 Feb 4.
8
Survival outcome of palliative primary tumor resection for colorectal cancer patients with synchronous liver and/or lung metastases: A retrospective cohort study in the SEER database by propensity score matching analysis.采用倾向评分匹配分析的 SEER 数据库回顾性队列研究:结直肠癌伴肝和/或肺转移患者姑息性原发灶切除的生存结局。
Int J Surg. 2020 Aug;80:135-152. doi: 10.1016/j.ijsu.2020.06.024. Epub 2020 Jul 4.
9
Prognostic value of preoperative systemic immune-inflammation index/albumin for patients with hepatocellular carcinoma undergoing curative resection.术前全身免疫炎症指数/白蛋白对接受根治性切除的肝细胞癌患者的预后价值
World J Gastroenterol. 2024 Dec 28;30(48):5130-5151. doi: 10.3748/wjg.v30.i48.5130.
10
Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.结直肠癌肝转移患者的术前化疗与手术切缘状态:一项倾向评分匹配分析
Am Surg. 2019 May 1;85(5):488-493.